BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15003298)

  • 1. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
    Muroi C; Terzic A; Fortunati M; Yonekawa Y; Keller E
    Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma acrolein levels and their association with delayed ischemic neurological deficits following aneurysmal subarachnoid haemorrhage: a pilot study.
    Garrett MC; McCullough-Hicks ME; Kim GH; Komotar RJ; Kellner CP; Hahn DK; Otten ML; Rynkowski MA; Merkow MB; Starke RM; Connolly ES
    Br J Neurosurg; 2008 Aug; 22(4):546-9. PubMed ID: 18686065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of brain natriuretic peptide in cerebral vasospasm.
    Sviri GE; Shik V; Raz B; Soustiel JF
    Acta Neurochir (Wien); 2003 Oct; 145(10):851-60; discussion 860. PubMed ID: 14577006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage.
    Munakata A; Ohkuma H; Nakano T; Shimamura N; Asano K; Naraoka M
    Neurosurgery; 2009 Mar; 64(3):423-8; discussion 428-9. PubMed ID: 19240603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
    Marlovits S; Striessnig G; Schuster R; Stocker R; Luxl M; Trattnig S; Vécsei V
    Arthroscopy; 2007 Jul; 23(7):696-702. PubMed ID: 17637403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
    Siironen J; Juvela S; Varis J; Porras M; Poussa K; Ilveskero S; Hernesniemi J; Lassila R
    J Neurosurg; 2003 Dec; 99(6):953-9. PubMed ID: 14705720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage.
    Carrera E; Kurtz P; Badjatia N; Fernandez L; Claassen J; Lee K; Schmidt JM; Connolly ES; Marshall RS; Mayer SA
    Arch Neurol; 2010 Apr; 67(4):434-9. PubMed ID: 20385909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
    Beck J; Raabe A
    Acta Neurochir Suppl; 2011; 110(Pt 2):147-50. PubMed ID: 21125461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report.
    Suzuki S; Sayama T; Nakamura T; Nishimura H; Ohta M; Inoue T; Mannoji H; Takeshita I
    Cerebrovasc Dis; 2011; 32(1):89-93. PubMed ID: 21677432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
    Lynch JR; Wang H; McGirt MJ; Floyd J; Friedman AH; Coon AL; Blessing R; Alexander MJ; Graffagnino C; Warner DS; Laskowitz DT
    Stroke; 2005 Sep; 36(9):2024-6. PubMed ID: 16051891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.